Status:
UNKNOWN
Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III)
Lead Sponsor:
Universidade do Vale do Sapucai
Conditions:
Anal Carcinoma
Anal Condyloma
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Cervical cancer is the third most frequent neoplasm in Brazilian women (estimated risk of 15.33 cases / 100,000 women by 2014), behind breast and colorectal cancer. This high incidence is explained b...
Eligibility Criteria
Inclusion
- Female patients aged 18-65 years with an anatomic pathology compatible with CIN II / CIN III, without restriction regarding skin color, race, ethnicity, religion; Patients of the Oncology Gynecology Service of the HCSL, registered in the hospital management system, in outpatient consultations; Those who agree to participate in the study and sign the ICF. Patients attended at the general gynecological surgery outpatient clinic (control group) with no evidence of colpocitological alteration.
- \-
Exclusion
- Patients who withdraw the consent term. History of previous anal cancer / anal intraepithelial neoplasia. Immunosuppressed: HIV, SLE, users of immunosuppressive and transplanted drugs.
- \-
Key Trial Info
Start Date :
August 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03241680
Start Date
August 2 2017
End Date
May 31 2018
Last Update
August 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lyliana C R Barbosa
Pouso Alegre, Minas Gerais, Brazil, 37550000